Kramer RL - Search Results

1

Fetal gender impact on multiple-marker screening results.

Bazzett LB, Yaron Y, O'Brien JE, Critchfield G, Kramer RL, Ayoub M, Johnson MP, Evans MI. Bazzett LB, et al. Among authors: kramer rl. Am J Med Genet. 1998 Apr 13;76(5):369-71. Am J Med Genet. 1998. PMID: 9556293

2

Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.

Kramer RL, Yaron Y, O'Brien JE, Critchfield G, Ayoub M, Johnson MP, Qualls CR, Evans MI. Kramer RL, et al. Am J Med Genet. 1998 Jan 13;75(2):176-8. Am J Med Genet. 1998. PMID: 9450880

3

Determinants of parental decisions after the prenatal diagnosis of Down syndrome.

Kramer RL, Jarve RK, Yaron Y, Johnson MP, Lampinen J, Kasperski SB, Evans MI. Kramer RL, et al. Am J Med Genet. 1998 Sep 23;79(3):172-4. doi: 10.1002/(sici)1096-8628(19980923)79:3<172::aid-ajmg4>3.0.co;2-p. Am J Med Genet. 1998. PMID: 9788556

4

Age-specific variation in aneuploidy incidence among biochemical screening programs.

Sokol AI, Kramer RL, Yaron Y, O'Brien JE, Muller F, Johnson MP, Evans MI. Sokol AI, et al. Among authors: kramer rl. Am J Obstet Gynecol. 1998 Oct;179(4):971-3. doi: 10.1016/s0002-9378(98)70199-1. Am J Obstet Gynecol. 1998. PMID: 9790381

5

2nd-trimester maternal serum marker results are not altered by delayed analysis.

Feldman B, Dvorin E, Phillips T, Kramer RL, Johnson MP, Evans MI. Feldman B, et al. Among authors: kramer rl. Fetal Diagn Ther. 1998 Sep-Oct;13(5):302-4. doi: 10.1159/000020858. Fetal Diagn Ther. 1998. PMID: 9813424

6

Molecular cytogenetic analysis of a de novo 5q31q33 deletion associated multiple congenital anomalies: case report.

Kramer RL, Feldman B, Ebrahim SA, Kasperski SB, Johnson MP, Evans MI. Kramer RL, et al. Am J Med Genet. 1999 Jan 15;82(2):143-5. Am J Med Genet. 1999. PMID: 9934978

7

Prenatal diagnosis of 46,XY/46,XX mosaicism: a case report.

Yaron Y, Feldman B, Kramer RL, Kasperski SB, Vo T, Feldman GL, Johnson MP, Evans MI, Ebrahim SA. Yaron Y, et al. Among authors: kramer rl. Am J Med Genet. 1999 May 7;84(1):12-4. Am J Med Genet. 1999. PMID: 10213039

8

Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.

Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP, Evans MI. Yaron Y, et al. Among authors: kramer rl. Am J Obstet Gynecol. 1999 Oct;181(4):968-74. doi: 10.1016/s0002-9378(99)70334-0. Am J Obstet Gynecol. 1999. PMID: 10521763

9

No effect of fetal sex on amniotic fluid alpha-fetoprotein.

Drugan A, Yaron Y, Murphy J, Ebrahim SA, Kramer RL, Johnson MP, Evans MI. Drugan A, et al. Among authors: kramer rl. Fetal Diagn Ther. 1997 Sep-Oct;12(5):301-3. doi: 10.1159/000264491. Fetal Diagn Ther. 1997. PMID: 9430214

10

What are the ethical and technical problems associated with multifetal pregnancy reduction?

Evans MI, Kramer RL, Yaron Y, Drugan A, Johnson MP. Evans MI, et al. Among authors: kramer rl. Clin Obstet Gynecol. 1998 Mar;41(1):46-54. doi: 10.1097/00003081-199803000-00010. Clin Obstet Gynecol. 1998. PMID: 9504223 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page